Research and Practice in Thrombosis and Haemostasis

Papers
(The H4-Index of Research and Practice in Thrombosis and Haemostasis is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board72
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction66
Uncertainties on the prognostic value of admission D‐dimer on venous thromboembolism occurrence in patients with COVID‐1961
Issue Information52
Letter in response to Colpani et al “A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”44
How We Write a Manuscript Discussion42
Factor V Leiden interferes with protein S activity assay42
Editorial Board41
Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”39
Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA37
Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans36
Andexanet alfa: trials just leave us with more questions34
Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia34
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT32
Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality30
Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis30
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies27
Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring25
Fibrinogen levels and bleeding risk in adult extracorporeal cardiopulmonary resuscitation: multicenter observational study subanalysis25
Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study24
Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 202124
Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function23
How to use and report data on D‐dimer testing in the COVID‐19 era?23
0.05341100692749